Arcutis Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Westlake Village, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Arcutis Biotherapeutics, Inc. has filed 834 SEC EDGAR filings since 09 Sep 2019

SEC filing history

Showing 376-400 of 834 matching filings.

Per page
25
Current page
16
S-8 File 333-277405

S-8

Filing date
27 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I/A File 005-91349

SC TO-I/A

Filing date
15 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91349

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91349

SCHEDULE 13G

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91349

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91349

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91349

MS INITIAL

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91349

SC 13G

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-276794

EFFECT filing

Filing date
08 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-276794

424B5

Filing date
08 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91349

13G INITIAL ANNUAL FILING - (ARQT)

Filing date
08 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-276794

UPLOAD filing

Filing date
05 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-276794

S-3

Filing date
31 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91349

ARCUTIS BIOTHERAPEUTICS, INC.

Filing date
31 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91349

SC 13G filing

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .